Disease_category,Disease,Protein,Protein_definition,Method,Nb_SNP,OR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP3,Insulin-like growth factor-binding protein 3,Inverse variance weighted,41,1.11 [0.98-1.26],0.0902037988622216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GDF15,Growth/differentiation factor 15,Inverse variance weighted,14,0.90 [0.62-1.30],0.573025156510284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL20,C-C motif chemokine 20,Inverse variance weighted,8,0.81 [0.57-1.16],0.248776972147064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,5,1.23 [0.71-2.13],0.462595000242954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,15,0.93 [0.79-1.10],0.39083723670508
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFASC,Neurofascin,Inverse variance weighted,19,0.90 [0.78-1.04],0.166971143823503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,19,0.96 [0.77-1.19],0.700267234739956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,21,1.07 [0.91-1.27],0.386626639359144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LY96,Lymphocyte antigen 96,Inverse variance weighted,19,0.94 [0.71-1.25],0.681111907515145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCN1,Ficolin-1,Inverse variance weighted,50,0.90 [0.80-1.01],0.0650315715535131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,22,1.15 [0.93-1.43],0.19932079973012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRCP,Lysosomal Pro-X carboxypeptidase,Inverse variance weighted,33,1.13 [0.95-1.33],0.171581749006051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF21,Fibroblast growth factor 21,Inverse variance weighted,4,0.88 [0.55-1.41],0.603231719071238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,1.05 [0.85-1.28],0.661821605031178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,8,1.36 [0.87-2.13],0.170671125486465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM3C,Protein FAM3C,Inverse variance weighted,5,1.37 [0.79-2.40],0.263315198623547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS3BP,Galectin-3-binding protein,Inverse variance weighted,30,1.02 [0.86-1.21],0.80158821408054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,32,0.98 [0.86-1.12],0.747436103930756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MFGE8,Lactadherin,Inverse variance weighted,26,0.97 [0.83-1.13],0.718497502746297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,17,0.98 [0.77-1.24],0.842175344867198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,24,0.97 [0.81-1.15],0.688828806094622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PENK,Proenkephalin-A,Inverse variance weighted,21,1.16 [0.95-1.42],0.147121555843615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD276,CD276 antigen,Inverse variance weighted,47,1.08 [0.98-1.18],0.108680224893633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG1A,Lithostathine-1-alpha,Inverse variance weighted,26,1.06 [0.90-1.24],0.493547723274846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD55,Complement decay-accelerating factor,Inverse variance weighted,27,1.09 [0.95-1.25],0.234368016074377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SDC1,Syndecan-1,Inverse variance weighted,14,1.05 [0.73-1.50],0.800770738961459
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,9,0.93 [0.55-1.58],0.794481700953139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,62,1.01 [0.93-1.10],0.785884838140808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,0.95 [0.68-1.33],0.769631951958896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRTG,Protogenin,Inverse variance weighted,34,1.05 [0.93-1.18],0.410826793254616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL12A_IL12B,Interleukin-12,Inverse variance weighted,57,1.08 [0.98-1.19],0.105124603762603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHAD,Chondroadherin,Inverse variance weighted,15,1.03 [0.87-1.23],0.713013373148236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZNRD2,Protein ZNRD2,Inverse variance weighted,10,0.81 [0.54-1.23],0.326768220978022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HEPH,Hephaestin,Inverse variance weighted,6,0.94 [0.72-1.24],0.677837448690493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,15,0.79 [0.61-1.03],0.0782073325037235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,0.89 [0.70-1.12],0.311568196221192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,13,1.08 [0.85-1.37],0.524547127493013
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,35,1.01 [0.89-1.15],0.860416673990042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBP2,Retinol-binding protein 2,Inverse variance weighted,6,1.20 [0.72-1.98],0.486075791673623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,11,0.88 [0.65-1.21],0.443478345304376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACY1,Aminoacylase-1,Inverse variance weighted,11,1.12 [0.87-1.44],0.396334121511443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,30,0.85 [0.72-1.02],0.076644267811113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,9,1.13 [0.75-1.71],0.570079850327436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL17C,Interleukin-17C,Inverse variance weighted,8,0.96 [0.66-1.39],0.829048756298961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,0.95 [0.59-1.55],0.842144417875374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA7A,Semaphorin-7A,Inverse variance weighted,25,1.09 [0.91-1.31],0.356664840785008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF8,Tumor necrosis factor ligand superfamily member 8,Inverse variance weighted,15,1.05 [0.84-1.31],0.653874835714665
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RTN4R,Reticulon-4 receptor,Inverse variance weighted,26,0.91 [0.78-1.07],0.242071971678427
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSL,Cathepsin L1,Inverse variance weighted,29,1.20 [0.96-1.50],0.111152672842032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,10,0.98 [0.73-1.30],0.874682966836634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,1.27 [0.87-1.85],0.221909159979979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RSPO3,R-spondin-3,Inverse variance weighted,11,0.99 [0.76-1.30],0.960651369673157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA3F,Semaphorin-3F,Inverse variance weighted,46,0.98 [0.82-1.18],0.842198508091106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRLB,Fc receptor-like B,Inverse variance weighted,65,1.13 [0.98-1.30],0.102152538862262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PALM2,Paralemmin-2,Inverse variance weighted,9,1.21 [0.94-1.57],0.147094985751668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PYY,Peptide YY,Inverse variance weighted,16,0.97 [0.77-1.24],0.833108421472789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,4,1.41 [0.92-2.17],0.117393795417995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPA2,Carboxypeptidase A2,Inverse variance weighted,27,0.98 [0.84-1.13],0.747172821069016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD164,Sialomucin core protein 24,Inverse variance weighted,11,1.02 [0.73-1.42],0.923643070907092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,23,1.03 [0.89-1.20],0.683686916982658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,5,0.80 [0.43-1.48],0.479679143794093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDH17,Protocadherin-17,Inverse variance weighted,47,0.99 [0.90-1.09],0.808134298733495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DTNB,Dystrobrevin beta,Inverse variance weighted,4,0.59 [0.28-1.27],0.179563230503883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL16,C-C motif chemokine 16,Inverse variance weighted,26,0.93 [0.84-1.03],0.163974272060716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,31,1.01 [0.88-1.14],0.929031360441797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,15,1.09 [0.88-1.34],0.436142469421535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCG2,Secretogranin-2,Inverse variance weighted,3,1.25 [0.65-2.41],0.510794926631316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,32,0.89 [0.80-1.00],0.0490537042163793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MVK,Mevalonate kinase,Inverse variance weighted,3,0.82 [0.43-1.55],0.536150734710548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFF1,Trefoil factor 1,Inverse variance weighted,14,1.06 [0.87-1.29],0.561181874791558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,8,0.86 [0.59-1.26],0.440532452849197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,1.05 [0.76-1.45],0.787290457501355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL25,C-C motif chemokine 25,Inverse variance weighted,49,0.95 [0.86-1.04],0.23828280703755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADM,Pro-adrenomedullin,Inverse variance weighted,4,1.10 [0.74-1.63],0.631323860723546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,1.43 [0.83-2.44],0.194915369236024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,22,0.97 [0.87-1.07],0.533789209203005
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPRC5C,G-protein coupled receptor family C group 5 member C,Inverse variance weighted,7,0.87 [0.60-1.26],0.461273956621157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,0.92 [0.72-1.17],0.502330975681272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSPB6,Heat shock protein beta-6,Inverse variance weighted,5,0.69 [0.40-1.20],0.192963848564119
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Inverse variance weighted,3,0.91 [0.51-1.64],0.75890124279377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOTCH1,Neurogenic locus notch homolog protein 1,Inverse variance weighted,9,1.09 [0.93-1.27],0.307904017199361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,40,0.94 [0.83-1.05],0.257079157545124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NGRN,Neugrin,Inverse variance weighted,4,0.72 [0.38-1.37],0.315156887326527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,18,1.13 [0.96-1.33],0.156006819837443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,18,1.16 [0.98-1.37],0.0795620063285088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,24,0.80 [0.67-0.95],0.0111369597105927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,10,0.87 [0.54-1.39],0.558305414995395
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,5,0.77 [0.55-1.08],0.124680796464245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCAM,Basal cell adhesion molecule,Inverse variance weighted,34,1.04 [0.94-1.16],0.467299584568346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL18,Interleukin-18,Inverse variance weighted,42,1.00 [0.89-1.12],0.972293066019576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,0.89 [0.78-1.01],0.0802982203771866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRN,Progranulin,Inverse variance weighted,46,1.04 [0.93-1.18],0.48207063577402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,30,1.02 [0.86-1.20],0.829014342994137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,25,1.01 [0.85-1.20],0.903861690064388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCN3,CCN family member 3,Inverse variance weighted,20,1.06 [0.89-1.27],0.51555731317882
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,5,1.13 [0.69-1.83],0.634200146727209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCN,Decorin,Inverse variance weighted,3,1.34 [0.56-3.22],0.512717107897702
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,9,1.15 [0.71-1.87],0.576824204714263
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRE2,Adhesion G protein-coupled receptor E2,Inverse variance weighted,19,1.03 [0.89-1.19],0.711592054943378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,12,1.13 [0.84-1.54],0.415536040060226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,16,0.72 [0.59-0.89],0.0024120354337969
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL7,C-C motif chemokine 7,Inverse variance weighted,14,0.86 [0.65-1.15],0.310330669730103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSO,Cathepsin O,Inverse variance weighted,22,1.00 [0.83-1.22],0.975798289311148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,6,0.96 [0.74-1.25],0.785029527791188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,9,0.84 [0.67-1.05],0.118763005309475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,1.63 [0.59-4.48],0.34202892189361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRD1,Natural killer cells antigen CD94,Inverse variance weighted,35,1.00 [0.89-1.11],0.956609746788939
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG1B,Lithostathine-1-beta,Inverse variance weighted,26,1.06 [0.92-1.23],0.405842064285271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Inverse variance weighted,2,1.14 [0.33-3.91],0.831609903738689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,29,1.08 [0.96-1.22],0.202875896408437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,27,1.00 [0.86-1.17],0.959548321193769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE6,Ribonuclease K6,Inverse variance weighted,20,1.14 [0.98-1.31],0.0801679374453533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DMP1,Dentin matrix acidic phosphoprotein 1,Inverse variance weighted,17,0.69 [0.50-0.96],0.0255076566949054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL6,Interleukin-6,Inverse variance weighted,6,0.79 [0.61-1.03],0.0825094573142034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Inverse variance weighted,4,1.10 [0.74-1.63],0.627841993932857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD27,CD27 antigen,Inverse variance weighted,18,1.07 [0.91-1.26],0.420407620022394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,0.96 [0.66-1.38],0.815474705679064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DLL1,Delta-like protein 1,Inverse variance weighted,13,0.74 [0.54-1.03],0.076232602890158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,22,0.99 [0.86-1.15],0.943634236731627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,17,0.84 [0.68-1.04],0.110866505309809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,24,1.13 [0.85-1.49],0.398031259527755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FBLN2,Fibulin-2,Inverse variance weighted,17,1.01 [0.87-1.18],0.876044958322649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAST,Gastrin,Inverse variance weighted,9,1.07 [0.77-1.50],0.679023882352463
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RETN,Resistin,Inverse variance weighted,28,0.89 [0.79-1.00],0.0439165134868831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EBI3_IL27,Interleukin-27,Inverse variance weighted,37,1.00 [0.87-1.14],0.982017769046149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,POF1B,Protein POF1B,Inverse variance weighted,4,1.07 [0.55-2.09],0.833954539380576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,42,0.96 [0.85-1.07],0.44397233404962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MUC13,Mucin-13,Inverse variance weighted,13,0.81 [0.64-1.02],0.0690623650090156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SELE,E-selectin,Inverse variance weighted,24,0.86 [0.77-0.96],0.0072083686906697
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C7,Complement component C7,Inverse variance weighted,60,1.00 [0.94-1.07],0.923281030575909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL19,Interleukin-19,Inverse variance weighted,21,0.99 [0.85-1.15],0.869549185067053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFF2,Trefoil factor 2,Inverse variance weighted,16,0.96 [0.75-1.23],0.740077687803583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,43,0.93 [0.86-1.01],0.0794730738893469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,8,0.78 [0.56-1.09],0.141342535914495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,24,0.99 [0.85-1.15],0.866646815097672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGA5,Integrin alpha-5,Inverse variance weighted,19,0.90 [0.70-1.15],0.387529063635634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,1.71 [0.91-3.22],0.0963003360808708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LPO,Lactoperoxidase,Inverse variance weighted,34,0.90 [0.80-1.01],0.0772964021500548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UMOD,Uromodulin,Inverse variance weighted,62,0.97 [0.90-1.04],0.379974381429565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HIP1R,Huntingtin-interacting protein 1-related protein,Inverse variance weighted,2,1.47 [0.90-2.42],0.124524540804097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,17,1.02 [0.83-1.27],0.824580562203559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH3,Cadherin-3,Inverse variance weighted,12,1.09 [0.64-1.86],0.743798184968975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ULBP2,UL16-binding protein 2,Inverse variance weighted,37,0.96 [0.89-1.05],0.386190820729091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRSS8,Prostasin,Inverse variance weighted,19,1.14 [0.86-1.52],0.366973046298908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD302,CD302 antigen,Inverse variance weighted,17,0.86 [0.71-1.04],0.117541817596435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.92 [0.33-2.51],0.863647886444989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ROBO1,Roundabout homolog 1,Inverse variance weighted,25,1.05 [0.87-1.28],0.600047425672825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,11,0.97 [0.74-1.27],0.805703177696925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DSC2,Desmocollin-2,Inverse variance weighted,16,1.03 [0.86-1.23],0.751964538739954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM3B,Protein FAM3B,Inverse variance weighted,26,0.93 [0.84-1.03],0.185016400633406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,1.00 [0.70-1.42],0.998077797844406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,12,0.94 [0.78-1.12],0.476495987799863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,17,0.90 [0.67-1.21],0.488236004881916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INHBC,Inhibin beta C chain,Inverse variance weighted,39,0.94 [0.84-1.04],0.213097724425043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,23,1.05 [0.86-1.28],0.621048927602265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,18,0.92 [0.76-1.10],0.36275148511157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHGB,Secretogranin-1,Inverse variance weighted,33,1.05 [0.94-1.16],0.400470111977397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,14,0.83 [0.60-1.14],0.253829147476235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,15,1.03 [0.76-1.38],0.860928571323623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,0.99 [0.69-1.42],0.973820489198489
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF1R,Macrophage colony-stimulating factor 1 receptor,Inverse variance weighted,27,0.93 [0.76-1.13],0.461662194834128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OCLN,Occludin,Inverse variance weighted,3,1.45 [0.93-2.26],0.10055993936759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRP1,Neuropilin-1,Inverse variance weighted,26,0.83 [0.70-1.00],0.0441944896773168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IMMT,MICOS complex subunit MIC60,Inverse variance weighted,2,1.33 [0.76-2.31],0.317257086898901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSN,Gelsolin,Inverse variance weighted,7,1.36 [0.67-2.76],0.38862555966919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGF,Placenta growth factor,Inverse variance weighted,8,0.90 [0.58-1.41],0.659825459717408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD59,CD59 glycoprotein,Inverse variance weighted,8,1.01 [0.75-1.38],0.924601229503372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD244,Natural killer cell receptor 2B4,Inverse variance weighted,28,0.89 [0.80-1.00],0.0568958691274043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,11,0.83 [0.69-1.00],0.048981820793107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,18,1.05 [0.87-1.28],0.594168532941175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BOC,Brother of CDO,Inverse variance weighted,15,1.04 [0.84-1.28],0.729198388202338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,Inverse variance weighted,2,0.77 [0.12-4.96],0.787220366259768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,36,1.07 [0.98-1.18],0.144369132395114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,22,1.08 [0.90-1.30],0.390467506129693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,75,0.96 [0.89-1.03],0.255028906687149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,36,1.12 [0.96-1.32],0.158461913793091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,31,1.21 [0.94-1.55],0.1424029490302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,18,0.99 [0.84-1.16],0.86520289613394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CR2,Complement receptor type 2,Inverse variance weighted,42,0.98 [0.78-1.22],0.827622684054302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,13,1.03 [0.82-1.29],0.813903574694607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAYN,Layilin,Inverse variance weighted,23,1.08 [0.90-1.29],0.425488492637206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB7,Integrin beta-7,Inverse variance weighted,46,0.99 [0.88-1.11],0.87029470504809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPNMB,Transmembrane glycoprotein NMB,Inverse variance weighted,22,0.96 [0.90-1.02],0.199383300016922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.16 [0.87-1.53],0.312906767953505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,11,0.88 [0.56-1.39],0.592255441894782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GOLM2,Protein GOLM2,Inverse variance weighted,14,1.10 [0.90-1.33],0.342899117392759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,14,1.08 [0.90-1.31],0.406204135571438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK4,Kallikrein-4,Inverse variance weighted,20,1.08 [0.93-1.26],0.321139567059616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OGN,Mimecan,Inverse variance weighted,37,0.85 [0.75-0.96],0.0083359941957253
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,25,1.00 [0.85-1.18],0.986778569958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REN,Renin,Inverse variance weighted,12,1.04 [0.85-1.26],0.715214758871121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH6,Cadherin-6,Inverse variance weighted,34,1.03 [0.94-1.14],0.525338934402101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WNT9A,Protein Wnt-9a,Inverse variance weighted,7,1.04 [0.71-1.51],0.843272611784464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALCAM,CD166 antigen,Inverse variance weighted,11,0.91 [0.71-1.18],0.488894664406167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MDK,Midkine,Inverse variance weighted,19,1.17 [0.92-1.50],0.204592451789937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,26,0.94 [0.81-1.09],0.393963562099992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CST3,Cystatin-C,Inverse variance weighted,13,1.09 [0.81-1.47],0.569214909583875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PI3,Elafin,Inverse variance weighted,20,0.99 [0.84-1.17],0.940162433119139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,6,0.92 [0.65-1.30],0.641185896127862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,14,1.11 [0.86-1.42],0.427969143532204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INHBB,Inhibin beta B chain,Inverse variance weighted,16,1.08 [0.74-1.56],0.696751057027509
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FSTL1,Follistatin-related protein 1,Inverse variance weighted,15,1.07 [0.82-1.40],0.603030453240466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,13,0.79 [0.60-1.04],0.0908655628611324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD163,Scavenger receptor cysteine-rich type 1 protein M130,Inverse variance weighted,38,1.17 [0.95-1.45],0.146832499361058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,10,1.03 [0.79-1.34],0.819828550660737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,5,0.88 [0.43-1.79],0.730267637901109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AREG,Amphiregulin,Inverse variance weighted,7,1.14 [0.75-1.73],0.544869139215219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPT,Dermatopontin,Inverse variance weighted,26,1.09 [0.93-1.29],0.287545138879594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC1,Sialoadhesin,Inverse variance weighted,31,1.07 [0.93-1.24],0.339510222625389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,14,0.81 [0.61-1.07],0.143819710148424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBP5,Retinol-binding protein 5,Inverse variance weighted,5,1.09 [0.65-1.81],0.750739153008953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INSR,Insulin receptor,Inverse variance weighted,6,0.62 [0.38-1.01],0.0527325219236131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOLR1,Folate receptor alpha,Inverse variance weighted,10,0.84 [0.57-1.23],0.358013266028737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE10,Inactive ribonuclease-like protein 10,Inverse variance weighted,27,1.02 [0.95-1.10],0.600687883476885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFA1_DEFA1B,Neutrophil defensin 1,Inverse variance weighted,31,1.00 [0.83-1.20],0.978678050834828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH15,Cadherin-15,Inverse variance weighted,22,0.83 [0.71-0.96],0.0150721217835414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GCG,Pro-glucagon,Inverse variance weighted,2,1.36 [0.53-3.45],0.521993327565646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,9,1.03 [0.79-1.36],0.805176399176466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD83,CD83 antigen,Inverse variance weighted,19,0.96 [0.77-1.19],0.709831738523395
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,20,1.12 [0.95-1.32],0.162915429466899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,19,1.06 [0.87-1.29],0.591269356859486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,28,0.98 [0.87-1.09],0.661805756956385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,11,0.85 [0.67-1.08],0.188507033611244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CGA,Glycoprotein hormones alpha chain,Inverse variance weighted,3,1.39 [0.38-5.09],0.617571136205296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,1.23 [0.73-2.07],0.437222503121827
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSAP,Prosaposin,Inverse variance weighted,13,0.92 [0.72-1.18],0.519059271340949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,0.95 [0.63-1.42],0.785604427802674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,15,0.91 [0.67-1.23],0.530111311773865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS9,Galectin-9,Inverse variance weighted,39,0.93 [0.81-1.07],0.300873247364455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,16,0.92 [0.78-1.09],0.352124683701343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRELP,Prolargin,Inverse variance weighted,14,0.95 [0.80-1.13],0.551364310240705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFD,Complement factor D,Inverse variance weighted,12,1.13 [0.90-1.41],0.302914353533703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,6,1.11 [0.71-1.72],0.648289385752322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,19,0.88 [0.73-1.06],0.165391362814523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCN4,CCN family member 4,Inverse variance weighted,40,1.08 [0.96-1.22],0.201821721112543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,22,0.99 [0.84-1.17],0.89748645406995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,31,0.97 [0.90-1.05],0.453189364170172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VWC2,Brorin,Inverse variance weighted,35,1.00 [0.86-1.18],0.95862267638063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL13,C-X-C motif chemokine 13,Inverse variance weighted,2,1.22 [0.19-8.02],0.835356323491341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,24,0.87 [0.78-0.98],0.0184995237615661
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYBPC1,"Myosin-binding protein C, slow-type",Inverse variance weighted,12,1.03 [0.65-1.64],0.885016159398184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,11,1.03 [0.84-1.26],0.79872863124757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Inverse variance weighted,4,0.97 [0.58-1.62],0.913685155505819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD109,CD109 antigen,Inverse variance weighted,71,1.03 [0.96-1.11],0.34975513227285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLSTN2,Calsyntenin-2,Inverse variance weighted,38,1.02 [0.91-1.13],0.763300120545626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPY,Pancreatic prohormone,Inverse variance weighted,23,0.73 [0.58-0.92],0.0073428314398155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,16,0.95 [0.83-1.08],0.418966520492869
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPY30,Protein dpy-30 homolog,Inverse variance weighted,2,0.35 [0.12-1.00],0.0501062542176308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRSS22,Brain-specific serine protease 4,Inverse variance weighted,11,1.00 [0.83-1.19],0.957492080216257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MILR1,Allergin-1,Inverse variance weighted,43,0.97 [0.90-1.04],0.385380834777696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH2,Cadherin-2,Inverse variance weighted,21,1.02 [0.74-1.41],0.888705983230022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,34,0.99 [0.89-1.10],0.808318866552881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL21,C-C motif chemokine 21,Inverse variance weighted,19,0.92 [0.69-1.23],0.59567977305648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLAMF7,SLAM family member 7,Inverse variance weighted,40,1.02 [0.92-1.14],0.67458253338816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,34,0.94 [0.84-1.04],0.214172608325758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSS,Cathepsin S,Inverse variance weighted,30,0.93 [0.81-1.06],0.29138283587547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE4,Ribonuclease 4,Inverse variance weighted,13,0.94 [0.79-1.12],0.478461864954931
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,66,1.03 [0.96-1.10],0.462242181218953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,17,0.97 [0.83-1.14],0.725888812588209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP7,Matrilysin,Inverse variance weighted,15,0.95 [0.77-1.17],0.600798363100612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,50,0.92 [0.86-1.00],0.0387311048763021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MME,Neprilysin,Inverse variance weighted,49,0.95 [0.84-1.08],0.428139627393042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,12,1.07 [0.84-1.36],0.575425151391131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,Wald ratio,1,0.63 [0.30-1.32],0.216458650250016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,6,0.69 [0.37-1.31],0.256865546051976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,0.77 [0.35-1.70],0.521349026209201
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADA2,Adenosine deaminase 2,Inverse variance weighted,18,1.15 [0.97-1.36],0.108991309019866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,41,0.93 [0.79-1.09],0.37396851313392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,22,0.93 [0.81-1.08],0.350758435024057
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1.07 [1.00-1.15],0.0575033983071035
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PVR,Poliovirus receptor,Inverse variance weighted,32,0.96 [0.87-1.06],0.423100896950971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,10,0.92 [0.57-1.48],0.720283627122433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BSG,Basigin,Inverse variance weighted,8,1.17 [0.84-1.62],0.356870666609051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300A,CMRF35-like molecule 8,Inverse variance weighted,35,0.98 [0.87-1.11],0.744748958677966
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,42,0.89 [0.77-1.02],0.101198007329262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSZ,Cathepsin Z,Inverse variance weighted,16,0.92 [0.80-1.06],0.2503502373107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSD,Cathepsin D,Inverse variance weighted,24,1.06 [0.90-1.24],0.495306644873459
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,21,0.99 [0.77-1.27],0.929914268293749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASET2,Ribonuclease T2,Inverse variance weighted,25,0.87 [0.75-1.01],0.0744320240250926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA12,Carbonic anhydrase 12,Inverse variance weighted,20,0.92 [0.79-1.06],0.250610227739459
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,17,1.16 [0.98-1.37],0.0890562759122713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GUCA2A,Guanylin,Inverse variance weighted,16,1.05 [0.84-1.32],0.679715123232377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMBP,Protein AMBP,Inverse variance weighted,5,0.90 [0.55-1.46],0.672072570923033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGSF9,Protein turtle homolog A,Inverse variance weighted,12,0.97 [0.80-1.17],0.716524543940832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,38,1.02 [0.93-1.12],0.66462183770238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,27,0.86 [0.70-1.05],0.135703728606867
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,22,1.14 [1.01-1.29],0.0296623453372046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPT2,Angiopoietin-2,Inverse variance weighted,11,0.96 [0.74-1.24],0.753873690313617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LMOD1,Leiomodin-1,Inverse variance weighted,6,0.84 [0.60-1.18],0.322191433592157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRK1,NKG2-D type II integral membrane protein,Inverse variance weighted,32,1.01 [0.90-1.14],0.818743571823947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CR1,Complement receptor type 1,Inverse variance weighted,39,1.03 [0.92-1.16],0.56713079616669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD46,Membrane cofactor protein,Inverse variance weighted,3,1.26 [0.75-2.12],0.376519644505098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,9,1.03 [0.71-1.49],0.878378586612269
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,30,1.03 [0.93-1.15],0.564978958295491
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AOC3,Membrane primary amine oxidase,Inverse variance weighted,36,0.90 [0.81-1.01],0.0649617092549115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,41,1.03 [0.95-1.11],0.526879970633946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,B2M,Beta-2-microglobulin,Inverse variance weighted,7,1.24 [0.60-2.59],0.55848844086595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,0.99 [0.80-1.21],0.912298901407278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOA4,Apolipoprotein A-IV,Inverse variance weighted,5,0.58 [0.29-1.17],0.128462480392944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NECTIN4,Nectin-4,Inverse variance weighted,12,0.92 [0.77-1.10],0.345319521167776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VEGFB,Vascular endothelial growth factor B,Inverse variance weighted,12,1.09 [0.82-1.45],0.562874143116064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STC1,Stanniocalcin-1,Inverse variance weighted,11,0.87 [0.63-1.21],0.41729855774286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,38,1.02 [0.89-1.16],0.780791810208036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,39,1.03 [0.91-1.17],0.607553548757371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,54,0.97 [0.87-1.08],0.569143429373904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF23,Fibroblast growth factor 23,Inverse variance weighted,17,1.33 [1.02-1.74],0.0333501342830692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH17,Cadherin-17,Inverse variance weighted,44,0.97 [0.88-1.07],0.496170933306516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,13,1.10 [0.83-1.47],0.512041570509343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCN2,Transcobalamin-2,Inverse variance weighted,66,1.01 [0.94-1.09],0.809148107626887
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,4,0.89 [0.63-1.26],0.504888918835376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,8,0.88 [0.64-1.20],0.420021368260498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,1.04 [0.91-1.19],0.556572297007052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,19,1.09 [0.94-1.26],0.237516177156818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,22,1.01 [0.83-1.23],0.910238983218583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NECTIN2,Nectin-2,Inverse variance weighted,8,1.21 [0.99-1.48],0.0620344479004581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEPTIN8,Septin-8,Inverse variance weighted,6,1.17 [0.81-1.69],0.405843668284433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPP6,Dipeptidyl aminopeptidase-like protein 6,Inverse variance weighted,14,0.98 [0.76-1.25],0.842032685178795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LY9,T-lymphocyte surface antigen Ly-9,Inverse variance weighted,36,1.10 [0.98-1.24],0.0985954954424371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,23,1.02 [0.91-1.14],0.76862628867323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TLR1,Toll-like receptor 1,Inverse variance weighted,17,0.96 [0.80-1.14],0.611923611764549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,5,0.77 [0.34-1.78],0.54518047067535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,13,1.06 [0.98-1.15],0.149760707075691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPPB,Natriuretic peptides B,Inverse variance weighted,3,1.05 [0.69-1.59],0.816041785030008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COLEC12,Collectin-12,Inverse variance weighted,13,1.06 [0.79-1.43],0.682513676349894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSPA2,Heat shock-related 70 kDa protein 2,Inverse variance weighted,2,1.07 [0.57-2.02],0.837153781595986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,19,1.03 [0.85-1.25],0.751014677316382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,1.14 [1.00-1.30],0.0522043562327428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,12,0.86 [0.69-1.07],0.181406042406327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,25,1.04 [0.77-1.40],0.800591549560012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,11,1.07 [0.87-1.32],0.497449412540724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,30,0.91 [0.80-1.04],0.160048110991738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,11,0.86 [0.64-1.15],0.304726657257903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,0.97 [0.78-1.21],0.817623749519681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,0.72 [0.35-1.49],0.376370945768565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCAN,Neurocan core protein,Inverse variance weighted,23,0.83 [0.67-1.04],0.10420722172556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,35,0.97 [0.82-1.14],0.714257149353212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TACSTD2,Tumor-associated calcium signal transducer 2,Inverse variance weighted,36,1.01 [0.92-1.12],0.777999852480129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,9,0.96 [0.68-1.36],0.808705348100135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,0.80 [0.41-1.58],0.519619166926159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,13,0.75 [0.55-1.04],0.0836589248676949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NTF3,Neurotrophin-3,Inverse variance weighted,18,1.26 [0.93-1.70],0.135881947303715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,16,0.83 [0.70-0.99],0.0366851484218301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGRP,Agouti-related protein,Inverse variance weighted,20,1.11 [0.90-1.38],0.31937041045276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM3D,Protein FAM3D,Inverse variance weighted,56,1.04 [0.93-1.15],0.505714103902959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCN5,CCN family member 5,Inverse variance weighted,12,0.81 [0.66-0.99],0.0418756397786959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,16,0.85 [0.71-1.01],0.0673386067812295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,1.19 [0.18-7.72],0.85901902994685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLXNB2,Plexin-B2,Inverse variance weighted,37,1.03 [0.96-1.10],0.403991600334137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,11,0.60 [0.41-0.87],0.0074904941895332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDCD1,Programmed cell death protein 1,Inverse variance weighted,24,1.07 [0.88-1.31],0.477486866642202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,26,1.04 [0.93-1.18],0.492325486812653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LCN15,Lipocalin-15,Inverse variance weighted,22,0.89 [0.79-1.00],0.0517671194672923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GDNF,Glial cell line-derived neurotrophic factor,Inverse variance weighted,15,1.01 [0.80-1.27],0.932240939321964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINF1,Pigment epithelium-derived factor,Inverse variance weighted,15,0.83 [0.70-0.99],0.0397416472495851
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,3,0.96 [0.35-2.69],0.945648041111068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHGA,Chromogranin-A,Inverse variance weighted,8,1.06 [0.82-1.37],0.66849068150384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GM2A,Ganglioside GM2 activator,Inverse variance weighted,26,1.00 [0.91-1.10],0.990773543190149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDN1,Endothelin-1,Inverse variance weighted,3,1.30 [0.90-1.86],0.156633147289238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,0.97 [0.59-1.58],0.901438001764467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLAMF6,SLAM family member 6,Inverse variance weighted,5,1.04 [0.77-1.42],0.797828693871257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMPRSS15,Enteropeptidase,Inverse variance weighted,11,0.86 [0.68-1.10],0.235306296055547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HGF,Hepatocyte growth factor,Inverse variance weighted,7,0.98 [0.63-1.52],0.941234846635028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,29,1.02 [0.90-1.15],0.795286781409085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA9,Carbonic anhydrase 9,Inverse variance weighted,11,0.82 [0.60-1.11],0.192753868774943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPON2,Spondin-2,Inverse variance weighted,8,1.23 [0.98-1.55],0.0689251445539294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPM,Carboxypeptidase M,Inverse variance weighted,23,0.88 [0.64-1.21],0.435759742368586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,30,0.89 [0.78-1.02],0.0842087565036198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SHISA5,Protein shisa-5,Inverse variance weighted,16,1.55 [1.08-2.23],0.0165458369637286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD48,CD48 antigen,Inverse variance weighted,32,0.99 [0.90-1.09],0.836514469231173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,19,0.90 [0.78-1.03],0.112802755919387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFA,Protransforming growth factor alpha,Inverse variance weighted,11,1.15 [0.82-1.61],0.425619576869195
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,5,1.20 [0.71-2.01],0.499229668940019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,61,1.02 [0.95-1.09],0.539544394892908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP10,Stromelysin-2,Inverse variance weighted,30,0.94 [0.80-1.10],0.431966732047982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OMD,Osteomodulin,Inverse variance weighted,15,0.85 [0.67-1.07],0.166716999871172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,37,0.96 [0.82-1.13],0.633217070805737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,20,1.01 [0.92-1.11],0.862827348078198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,0.99 [0.90-1.10],0.910953239839682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,38,1.01 [0.91-1.13],0.826613604289663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOF,Apolipoprotein F,Inverse variance weighted,12,0.97 [0.80-1.18],0.760443167187481
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,0.97 [0.57-1.64],0.899889766105158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,19,0.94 [0.82-1.07],0.336364533751252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,29,0.87 [0.72-1.06],0.160792808762219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,28,1.03 [0.90-1.17],0.694471901745217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VEGFD,Vascular endothelial growth factor D,Inverse variance weighted,7,1.12 [0.77-1.64],0.55388632175774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMIGO2,Amphoterin-induced protein 2,Inverse variance weighted,26,0.75 [0.61-0.93],0.0091658605802967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,66,1.01 [0.93-1.09],0.860679524897949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DRAXIN,Draxin,Inverse variance weighted,38,1.01 [0.90-1.13],0.852740608319494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,28,1.00 [0.91-1.09],0.980781187260198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLAMF8,SLAM family member 8,Inverse variance weighted,28,1.05 [0.99-1.12],0.122397401907282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,10,0.97 [0.79-1.18],0.738887862365005
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,26,0.89 [0.76-1.03],0.114864864866397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,30,0.95 [0.78-1.14],0.558515716179826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,42,1.04 [0.94-1.16],0.437761132073244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,18,0.80 [0.61-1.04],0.0925221820485112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCAN,Brevican core protein,Inverse variance weighted,15,0.84 [0.68-1.03],0.0955260059544963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH1,Cadherin-1,Inverse variance weighted,17,0.85 [0.70-1.02],0.0788481483756131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD160,CD160 antigen,Inverse variance weighted,36,1.04 [0.89-1.21],0.639762981394575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFF3,Trefoil factor 3,Inverse variance weighted,10,0.94 [0.70-1.26],0.682965295398425
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,9,0.95 [0.69-1.31],0.752518749243521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL11,Eotaxin,Inverse variance weighted,11,0.95 [0.77-1.16],0.585113011154779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,18,0.85 [0.63-1.15],0.289124907993176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,15,1.17 [0.86-1.59],0.313701053633446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PALM,Paralemmin-1,Inverse variance weighted,10,0.81 [0.59-1.11],0.188294573157184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,4,1.22 [0.72-2.06],0.468186737864381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,8,1.00 [0.83-1.21],0.961030924847516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THBS2,Thrombospondin-2,Inverse variance weighted,33,1.01 [0.89-1.14],0.927506826447947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP4,"Fatty acid-binding protein, adipocyte",Inverse variance weighted,2,0.54 [0.21-1.38],0.197806972488852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,17,1.06 [0.79-1.43],0.69746841152908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,23,0.98 [0.84-1.15],0.821373378508918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,15,1.11 [0.84-1.47],0.469951716830714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,37,1.02 [0.93-1.13],0.648752440655682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPON1,Spondin-1,Inverse variance weighted,25,1.06 [0.91-1.22],0.465165199591031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,3,1.01 [0.59-1.74],0.965112072042005
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF5,Fibroblast growth factor 5,Inverse variance weighted,43,1.04 [0.94-1.14],0.452925019130372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD99,CD99 antigen,Inverse variance weighted,4,1.38 [0.70-2.73],0.346500405608874
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,34,0.98 [0.84-1.15],0.808093356667507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLMP,CXADR-like membrane protein,Inverse variance weighted,15,1.04 [0.89-1.22],0.599763658126085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,6,1.25 [0.91-1.72],0.16150384958797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,6,0.94 [0.67-1.31],0.709124178234295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THBD,Thrombomodulin,Inverse variance weighted,16,1.17 [0.98-1.40],0.0797990621723503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALCA,Calcitonin,Inverse variance weighted,17,0.98 [0.71-1.34],0.878534798180062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD7,T-cell antigen CD7,Inverse variance weighted,12,1.04 [0.92-1.17],0.572136220932288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FSTL3,Follistatin-related protein 3,Inverse variance weighted,7,0.68 [0.44-1.06],0.0919867034064333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP12,Macrophage metalloelastase,Inverse variance weighted,21,0.94 [0.84-1.06],0.329746786477632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSG1,Pregnancy-specific beta-1-glycoprotein 1,Inverse variance weighted,74,0.98 [0.92-1.05],0.552581352163768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYL3,Myosin light chain 3,Inverse variance weighted,13,1.04 [0.68-1.59],0.866179975807254
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD70,CD70 antigen,Inverse variance weighted,39,0.90 [0.82-0.99],0.025180003313912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,13,0.77 [0.58-1.03],0.0816673136802539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300E,CMRF35-like molecule 2,Inverse variance weighted,36,0.93 [0.82-1.05],0.250966472778972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK11,Kallikrein-11,Inverse variance weighted,19,0.90 [0.78-1.04],0.158020982223783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,11,0.91 [0.81-1.01],0.0870435971454325
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGRN,Agrin,Inverse variance weighted,31,1.15 [0.96-1.38],0.121023121817397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFC1,Cryptic protein,Inverse variance weighted,11,0.78 [0.52-1.15],0.211926092275637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFNA1,Ephrin-A1,Inverse variance weighted,15,0.94 [0.78-1.13],0.499940364891019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,20,0.95 [0.74-1.21],0.672728689643103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS4,Galectin-4,Inverse variance weighted,19,0.85 [0.73-0.99],0.0309038813653973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT18,"Keratin, type I cytoskeletal 18",Inverse variance weighted,8,1.13 [0.79-1.62],0.493224791137243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,XG,Glycoprotein Xg,Inverse variance weighted,2,0.32 [0.12-0.89],0.0282851374189762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,21,1.18 [0.98-1.43],0.0803292058678003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNCG,Gamma-synuclein,Inverse variance weighted,49,1.03 [0.94-1.12],0.575847523850734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DKK4,Dickkopf-related protein 4,Inverse variance weighted,18,1.00 [0.63-1.57],0.988283009409767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRG2,Adhesion G-protein coupled receptor G2,Inverse variance weighted,8,0.76 [0.48-1.21],0.246458872553743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,63,1.09 [0.99-1.20],0.0669141439897003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,1.06 [0.93-1.21],0.378600892004857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,10,1.01 [0.76-1.33],0.952956474354506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,4,0.90 [0.71-1.15],0.404652813079005
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,76,1.02 [0.97-1.08],0.463798726606653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IDUA,Alpha-L-iduronidase,Inverse variance weighted,55,0.99 [0.91-1.08],0.874245849317183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,3,0.95 [0.52-1.74],0.871123049649755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",Inverse variance weighted,4,1.09 [0.59-1.99],0.792120691921641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB2,Integrin beta-2,Inverse variance weighted,20,1.03 [0.82-1.30],0.767205157715949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOMO1,Nodal modulator 1,Inverse variance weighted,26,0.91 [0.81-1.02],0.11359732483614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,1.10 [0.84-1.44],0.472948200053744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,0.86 [0.69-1.06],0.166011574450199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPY,Pro-neuropeptide Y,Inverse variance weighted,18,0.93 [0.69-1.26],0.644008463681958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HYAL1,Hyaluronidase-1,Inverse variance weighted,23,0.99 [0.86-1.13],0.836997744882732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PKD1,Polycystin-1,Inverse variance weighted,23,0.89 [0.76-1.03],0.122178344217972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRE5,Adhesion G protein-coupled receptor E5,Inverse variance weighted,16,1.07 [0.89-1.28],0.496761146377917
